|

Parkinson's Disease Clinical Trials in Ohio

22 recruiting studies across 2 cities

Browse by City

Cleveland
17 trials
Columbus
8 trials

All Trials in Ohio

Phase
Trial Phase Dist.
Registry of Deep Brain Stimulation With the VERCISE™ System: Vercise DBS Registry—<1 mi
Parkinson's Foundation PD GENEration Genetic Registry—<1 mi
A Study to Evaluate the Effectiveness of Two Doses of AP-472 as Adjunctive Therapy to Levodopa in Parkinson's Disease (PD) Participants With Motor FluctuationsPhase 2<1 mi
A Study of AAV2-GDNF in Adults With Moderate Parkinson's Disease (REGENERATE-PD)Phase 2<1 mi
A Phase 2 Study and Open-Label Extension of NEU-411 in Companion Diagnostic-Positive Participants With Early Parkinson's DiseasePhase 2<1 mi
A Study to Assess Safety and Efficacy of Surgical Implant of RNDP-001 in Patients With Idiopathic Parkinson's DiseasePhase 1/2<1 mi
Distinguishing Between Alzheimer's Disease, Lewy Body Dementia, and Parkinson's Disease—<1 mi
A Study of Buntanetap in Participants With PDPhase 2/3<1 mi
Personalized Real-Time DBS and PD MechanismsPhase 4<1 mi
A Study to Evaluate the Efficacy and Safety of Intravenous (IV) Prasinezumab in Participants With Early-Stage Parkinson's DiseasePhase 3<1 mi
PPMI Clinical - Establishing a Deeply Phenotyped PD Cohort—<1 mi
BOOST-PD A Naturalistic Study on IPX-203 for Parkinson's DiseasePhase 4<1 mi
A Study of CREXONT (Carbidopa and Levodopa) Extended-Release Capsules in Participants With Parkinson's DiseasePhase 4<1 mi
A US Study That Observes How Parkinson's Disease Changes Over Time in Patients Who Still Have Movement Symptoms Despite Taking Parkinson's Medications—<1 mi
Remote Dynamic Cycling for the Customized Off-site Rehab in Parkinson's DiseaseN/A<1 mi
Virtual tES Device Treatment for Parkinson's Disease Motor SymptomsPhase 1/2<1 mi
Deep Brain Stimulation for Visuomotor Function in Parkinson's Disease—<1 mi
Black and African Americans Connections to Parkinson's Disease (BLAAC PD)—<1 mi
Deep Brain Stimulation Neural Recordings of Varied Stimulation During Sleep in Parkinson's DiseaseN/A<1 mi
Genetics and Aerobic Exercise to Slow Parkinson's Disease TrialN/A<1 mi
A Post-Approval Registry for Exablate 4000 Type 1.0 and Type 1.1 for Unilateral Thalamotomy for the Treatment of Medication-Refractory Tremor Dominant Idiopathic Parkinson's Disease—<1 mi
Pimavanserin vs. Quetiapine for Treatment of Parkinson's PsychosisPhase 4<1 mi

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.